Potential risk biomarkers found for schizophrenia resulting from cannabis use

 Potential risk biomarkers found for schizophrenia resulting from cannabis use

A new study has analyzed and compared the fatty acids in the blood of individuals with schizophrenia, of those with cannabis use disorder and of those with both diagnoses, with the aim of shedding light on new biomarkers and improving the understanding of the…

Cannabis is one of the most widely used substances in the world, with some 228 million users between the ages of 15 and 64. The risk of developing schizophrenia increases significantly with cannabis …